Tempus AI, Inc. (TEM) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$78.97

From 52W high−8.13%

Volume1.02M

Market cap$14.26B

P/E (TTM)—

P/S (TTM)9.4x

Div yield—

Key dataNov 4, 2026

Open

$78.97

From 52W high

−8.13%

Volume

1.02M

Market cap

$14.26B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−159.0x

P/E (TTM)

—

RSI (14)

60.1

MomentumView details →

1D Return

+0.46%

YTD Return

+35.61%

SummaryUpdated Sep 1, 2026

Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company founded in 2015 and headquartered in Chicago, Illinois. The company was originally incorporated as Tempus Labs, Inc. before changing its name to Tempus AI, Inc. in January 2023 to reflect its focus on artificial intelligence applications in healthcare. Tempus operates as a precision medicine platform that combines genomic testing, clinical data analytics, and AI-powered insights to advance cancer care and treatment decisions. The company went public in 2012 and has grown through strategic acquisitions and partnerships to become a significant player in the molecular diagnostics and healthcare data analytics space.

Ask drillr about Tempus AI, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−159.0x

EV/Sales

11.5x

P/S (TTM)

9.4x

P/B (TTM)

28.5x

ProfitabilityView details →

Gross Margin

66.50%

Net Margin

−12.54%

EBITDA Margin

−7.22%

ROE (TTM)

−37.83%

ROA (TTM)

−7.72%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

+36.56%

EPS YoY

+11.79%

FCF YoY

+73.22%

Revenue CAGR 3Y

+58.29%

EPS CAGR 3Y

+69.35%

EBITDA YoY

−19.45%

MomentumView details →

1D Return

+0.46%

YTD Return

+35.61%

1Y Return

−5.22%

RSI (14)

60.1

vs 50D SMA

+12.66%

vs 200D SMA

+40.41%

Capital & dividendView details →

Debt/Equity

2.51x

Current Ratio

2.61x

Quick Ratio

2.48x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.07

EPS Surprise

174.71%

Beats (12Q)

5/12

Next Q EPS Est

−$0.02

Avg Surprise (4Q)

−81.05%

Rev Surprise

0.52%

Financials snapshotView financials →

Revenue (TTM)

1.51B

Net Income (TTM)

−189.29M

Op. CF (TTM)

−108.37M

Next earningsFeb 23, 2027 →

Latest newsMore news →

Tempus AI shares traded higher on Monday.2d ago

Tempus AI reported third-quarter 2026 revenue of $411.5 million, up 23% year over year, and a net loss of $14.9 million.2d ago

Similar companies

BrightSpring Health Services, Inc. Common StockBTSG Ping An Healthcare and Technology Company Limited01833.HK Hinge Health, Inc.HNGE XtalPi Holdings Ltd02228.HK HealthEquity, Inc.HQY 10x Genomics, Inc.TXG Find similar companies →

Latest newsMore news →

Tempus AI shares traded higher on Monday.2d ago Tempus AI reported third-quarter 2026 revenue of $411.5 million, up 23% year over year, and a net loss of $14.9 million.2d ago Tempus AI announced that its xR assay received European Union IVDR certification as a Class C in vitro diagnostic device.9d ago